Publication trends of research on sepsis and programmed cell death during 2002-2022: A 20-year bibliometric analysis

被引:3
作者
Li, Jing-yan [1 ]
Yao, Ren-qi [2 ,3 ]
Xie, Min-yue [4 ]
Zhou, Qi-yuan [1 ]
Zhao, Peng-yue [2 ,3 ]
Tian, Ying-ping [1 ]
Yao, Yong-ming [1 ,2 ,3 ]
机构
[1] Hebei Med Univ, Dept Emergency, Hosp 2, Shijiazhuang, Peoples R China
[2] Chinese Peoples Liberat Army PLA Gen Hosp, Translat Med Res Ctr, Med Innovat Res Div, Beijing, Peoples R China
[3] Chinese Peoples Liberat Army PLA Gen Hosp, Med Ctr 4, Beijing, Peoples R China
[4] Capital Med Univ, Beijing Tongren Hosp, Beijing, Peoples R China
来源
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY | 2022年 / 12卷
基金
中国国家自然科学基金;
关键词
bibliometric analysis; publication; sepsis; programmed cell death; infection; SEPTIC SHOCK; INFLAMMATORY RESPONSE; MOLECULAR-MECHANISMS; PYROPTOSIS; APOPTOSIS; IMMUNOSUPPRESSION; INFLAMMASOMES; MACROPHAGES; FERROPTOSIS; DEPLETION;
D O I
10.3389/fcimb.2022.999569
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BackgroundSepsis is considered an intractable dysfunction that results from the disordered host immune response to uncontrolled infection. Even though the precise mechanism of sepsis remains unclear, scientific advances have highlighted the key role of various programmed cell death processes in the pathophysiology of sepsis. The current study aims to explore the worldwide research trend on programmed cell death in the setting of sepsis and assesses the achievements of publications from various countries, institutions, journals, and authors globally. Material and methodsAssociated publications during 2002-2022 with the topical subject of sepsis and programmed cell death were extracted from the Web of Science. VOSviewer was utilized to evaluate and map the published trend in the relevant fields. ResultsAll 2,037 relevant manuscripts with a total citation of 71,575 times were screened out by the end of 1 January 2022. China accounted for the largest number of publications (45.07%) and was accompanied by corporate citations (11,037) and H-index (48), which ranked second globally. The United States has been ranked first place with the highest citations (30,775) and H-index (88), despite a low publication number (29.95%), which was subsequent to China. The journal Shock accounted for the largest number of publications in this area. R. S. Hotchkiss, affiliated with Washington University, was considered to have published the most papers in the relevant fields (57) and achieved the highest citation frequencies (9,523). The primary keywords on the topic of programmed cell death in sepsis remarkably focused on "inflammation" "immunosuppression", and "oxidative stress", which were recognized as the core mechanisms of sepsis, eventually attributing to programmed cell death. The involved research on programmed cell death induced by immune dysregulation of sepsis was undoubtedly the hotspot in the pertinent areas. ConclusionsThe United States has been academically outstanding in sepsis-related research. There appears to be an incompatible performance between publications and quantity with China. Frontier advances may be consulted in the journal Shock. The leading-edge research on the scope of programmed cell death in sepsis should preferably focus on immune dissonance-related studies in the future.
引用
收藏
页数:14
相关论文
共 57 条
  • [1] Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice
    Angeli, Jose Pedro Friedmann
    Schneider, Manuela
    Proneth, Bettina
    Tyurina, Yulia Y.
    Tyurin, Vladimir A.
    Hammond, Victoria J.
    Herbach, Nadja
    Aichler, Michaela
    Walch, Axel
    Eggenhofer, Elke
    Basavarajappa, Devaraj
    Radmark, Olof
    Kobayashi, Sho
    Seibt, Tobias
    Beck, Heike
    Neff, Frauke
    Esposito, Irene
    Wanke, Ruediger
    Foerster, Heidi
    Yefremova, Olena
    Heinrichmeyer, Marc
    Bornkamm, Georg W.
    Geissler, Edward K.
    Thomas, Stephen B.
    Stockwell, Brent R.
    O'Donnell, Valerie B.
    Kagan, Valerian E.
    Schick, Joel A.
    Conrad, Marcus
    [J]. NATURE CELL BIOLOGY, 2014, 16 (12) : 1180 - U120
  • [2] Thanks to Trauma A Delayed Diagnosis of Pott Disease
    Avcu, Gulhadiye
    Bal, Zumrut Sahbudak
    Duyu, Muhterem
    Akkus, Eser
    Karapinar, Bulent
    Vardar, Fadil
    [J]. PEDIATRIC EMERGENCY CARE, 2015, 31 (12) : E17 - E18
  • [3] REDOX THERAPY IN NEONATAL SEPSIS: REASONS, TARGETS, STRATEGY, AND AGENTS
    Bajcetic, Milica
    Spasic, Snezana
    Spasojevic, Ivan
    [J]. SHOCK, 2014, 42 (03): : 179 - 184
  • [4] Pyroptosis: host cell death and inflammation
    Bergsbaken, Tessa
    Fink, Susan L.
    Cookson, Brad T.
    [J]. NATURE REVIEWS MICROBIOLOGY, 2009, 7 (02) : 99 - 109
  • [5] Sir Isaac Newton, sepsis, SIRS, and CARS
    Bone, RC
    [J]. CRITICAL CARE MEDICINE, 1996, 24 (07) : 1125 - 1128
  • [6] Neutrophil extracellular traps kill bacteria
    Brinkmann, V
    Reichard, U
    Goosmann, C
    Fauler, B
    Uhlemann, Y
    Weiss, DS
    Weinrauch, Y
    Zychlinsky, A
    [J]. SCIENCE, 2004, 303 (5663) : 1532 - 1535
  • [7] Inflammasomes: mechanism of assembly, regulation and signalling
    Broz, Petr
    Dixit, Vishva M.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2016, 16 (07) : 407 - 420
  • [8] Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis
    Chang, Katherine
    Svabek, Catherine
    Vazquez-Guillamet, Cristina
    Sato, Bryan
    Rasche, David
    Wilson, Strother
    Robbins, Paul
    Ulbrandt, Nancy
    Suzich, JoAnn
    Green, Jonathan
    Patera, Andriani C.
    Blair, Wade
    Krishnan, Subramaniam
    Hotchkiss, Richard
    [J]. CRITICAL CARE, 2014, 18 (01):
  • [9] Mechanisms of 4-Hydroxy-2-nonenal Induced Pro- and Anti-Apoptotic Signaling
    Chaudhary, Pankaj
    Sharma, Rajendra
    Sharma, Abha
    Vatsyayan, Rit
    Yadav, Sushma
    Singhal, Sharad S.
    Rauniyar, Navin
    Prokai, Laszlo
    Awasthi, Sanjay
    Awasthi, Yogesh C.
    [J]. BIOCHEMISTRY, 2010, 49 (29) : 6263 - 6275
  • [10] "Merinoff Symposium 2010: Sepsis"-Speaking with One Voice
    Czura, Christopher J.
    [J]. MOLECULAR MEDICINE, 2011, 17 (1-2) : 2 - 3